SCHEMBL22967752

SCHEMBL22967752

Cc1ccc(O)c(C(C)(C)C)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.39
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
ALOX15 P16050 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
CYP2C9 P11712 1/20 0.34
MIF P14174 1/20 0.34
TYR P14679 1/20 0.34
HTT P42858 1/20 0.34
NFE2L2 Q16236 1/20 0.34
ESR2 Q92731 3/20 0.34
AR P10275 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13025564 0.83 ESR2 (0.35) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL11891649 0.81 HDAC3 (0.34) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17030737 0.80 ALDH1A1 (0.37) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL36472 0.79 ESR1 (0.43) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL29359879 0.79 ESR1 (0.43) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL27905066 0.79 ESR1 (0.43) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL16498751 0.78 ALDH1A1 (0.43) ALDH1A1TDP1ALOX15HSD17B10HPGD
SCHEMBL8890931 0.77 ESR1 (0.41) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL31612514 0.77 GABRA1 (0.45) ESR1ALDH1A1TDP1ALOX15HSD17B10
SCHEMBL4503429 0.77 GABRA1 (0.45) ESR1ALDH1A1TDP1ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS KRAS, NRAS, APC ESR1 2709/4885ALDH1A1 3926/4885TDP1 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.